Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

2.50
+0.07002.88%
Post-market: 2.540.0400+1.60%19:21 EST
Volume:114.62K
Turnover:285.91K
Market Cap:139.76M
PE:-2.81
High:2.56
Open:2.42
Low:2.40
Close:2.43
52wk High:3.28
52wk Low:0.5100
Shares:55.90M
Float Shares:14.34M
Volume Ratio:0.82
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8884
EPS(LYR):-0.2830
ROE:-66.80%
ROA:-38.67%
PB:2.52
PE(LYR):-8.83

Loading ...

Connect Biopharma Initiated at Buy by Lake Street

Dow Jones
·
Dec 02

Connect Biopharma Holdings to Present at Evercore Healthcare Conference

Reuters
·
Nov 24

Connect Biopharma Reports Significant Loss Amid Development Efforts

TIPRANKS
·
Nov 18

Connect Biopharma Price Target Maintained With a $10.00/Share by BTIG

Dow Jones
·
Nov 13

Connect Biopharma Hldgs Q3 EPS $(0.31) Misses $(0.27) Estimate, Sales $16.000K Down From $1.219M YoY

Benzinga
·
Nov 12

Connect Biopharma Reports Q3 2025 Results and Advances Rademikibart Clinical Programs

Reuters
·
Nov 12

Connect Biopharma reports third quarter 2025 financial results

Reuters
·
Nov 12

Press Release: Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update

Dow Jones
·
Nov 12

Connect Biopharma Holdings Ltd : Btig Initiates Coverage With Buy Rating; Price Target $10

THOMSON REUTERS
·
Oct 31

Connect Biopharma Initiated at Buy by BTIG

Dow Jones
·
Oct 31

Connect Biopharma initiated with a Buy at BTIG

TIPRANKS
·
Oct 31

Buy Rating for Connect Biopharma: Promising Clinical Data and Market Potential for Rademikibart

TIPRANKS
·
Sep 29

Connect Biopharma presents data on rademikibart at ERS Congress

TIPRANKS
·
Sep 29

Connect Biopharma Announces Promising Phase 2 Data for Rademikibart in Asthma and COPD, with Topline Results Expected in 1H 2026

Reuters
·
Sep 29

Connect Biopharma Executives Increase Share Holdings

TIPRANKS
·
Sep 16

BRIEF-Connect Biopharma Completes Termination Of Its American Depositary Receipt Program And Directly Lists Its Ordinary Shares On Nasdaq

Reuters
·
Sep 03

Connect Biopharma Unveils Rademikibart's Promising Potential for Asthma and COPD Treatment in Latest Presentation

Reuters
·
Sep 03

Connect Biopharma Completes Termination of Its American Depositary Receipt Program and Directly Lists Its Ordinary Shares on Nasdaq

THOMSON REUTERS
·
Sep 03

Connect Biopharma Holdings Ltd. Transitions to Direct Nasdaq Listing, Enhancing U.S. Market Focus

Reuters
·
Sep 03

Connect Biopharma Holdings Ltd. to Participate in Cantor Global Healthcare and H.C. Wainwright Conferences

Reuters
·
Aug 27